Greg Steube Periodic Transaction Report

Filed Mar 15, 2023 · House Clerk · 2 transactions

U.S. Representative · R · FL-17 · All trades by Greg Steube

On March 15, 2023, Rep. Greg Steube (R-FL-17) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 purchases) dated Feb 6, 2023 through Feb 17, 2023.

The filing covers 1 ticker, including $SNV.

Reported amount ranges sum to $2K–$30K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 37 days.

2 transactions were reported under a spouse, dependent child, or joint account rather than the member directly.

Source document: House Clerk filing 20022574

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Greg Steube · Bought $SNV · Feb 17 · $1K–$15K

0.31LOW

Disclosure speedx 0.250.30

Trade sizex 0.250.20

Cluster activityx 0.150.00

Track recordx 0.350.52

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Greg Steube

Get an email the moment Greg Steube files the next one. Free, no card, no spam.

Follow free →

Transactions

2 / 0

Buys / sells

Tickers

37d

Longest lag

Tickers in this filing

SNV2

Transactions disclosed

Trade date	Ticker	Asset	Type	Owner	Amount	Lag
Feb 6, 2023	SNV	Synovus Financial Corp. (SNV) [ST]	buy	Spouse	$1K–$15K	37d
Feb 17, 2023	SNV	Synovus Financial Corp. (SNV) [ST]	buy	Spouse	$1K–$15K	26d

Other recent filings by Greg Steube

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →